BR112018007634A2 - tablete oral revestido estável - Google Patents

tablete oral revestido estável

Info

Publication number
BR112018007634A2
BR112018007634A2 BR112018007634A BR112018007634A BR112018007634A2 BR 112018007634 A2 BR112018007634 A2 BR 112018007634A2 BR 112018007634 A BR112018007634 A BR 112018007634A BR 112018007634 A BR112018007634 A BR 112018007634A BR 112018007634 A2 BR112018007634 A2 BR 112018007634A2
Authority
BR
Brazil
Prior art keywords
oral tablet
coated oral
stable coated
stable
present
Prior art date
Application number
BR112018007634A
Other languages
English (en)
Inventor
Dee Kennie
Josefina Santos Rita
Mendoza Wendell
Original Assignee
Dee Kennie
Josefina Santos Rita
Mendoza Wendell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dee Kennie, Josefina Santos Rita, Mendoza Wendell filed Critical Dee Kennie
Publication of BR112018007634A2 publication Critical patent/BR112018007634A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção diz respeito a tabletes não efervescentes para engolir contendo vitamina c e zinco, onde a vitamina c está presente em concentração elevada e é estável em relação à oxidação e formação de dióxido de carbono.
BR112018007634A 2015-10-16 2015-10-16 tablete oral revestido estável BR112018007634A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2015/000016 WO2017065623A1 (en) 2015-10-16 2015-10-16 Stable composition of vitamin c and zinc tablet

Publications (1)

Publication Number Publication Date
BR112018007634A2 true BR112018007634A2 (pt) 2018-11-06

Family

ID=58517594

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018007634A BR112018007634A2 (pt) 2015-10-16 2015-10-16 tablete oral revestido estável

Country Status (8)

Country Link
KR (1) KR102089721B1 (pt)
CN (1) CN108347990A (pt)
BR (1) BR112018007634A2 (pt)
HK (1) HK1257130A1 (pt)
MY (1) MY191729A (pt)
PH (1) PH12018500791A1 (pt)
TW (1) TW201716063A (pt)
WO (1) WO2017065623A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114469883A (zh) * 2020-10-27 2022-05-13 河北科星药业有限公司 一种治疗仔猪坏血症的氨酪酸维生素c片、制备方法和应用
WO2023031946A1 (en) * 2021-09-01 2023-03-09 Kusum Healthcare Pvt. Ltd. Effervescent pharmaceutical composition of ascorbic acid and zinc
CN114306269A (zh) * 2021-12-27 2022-04-12 西华大学 一种柠檬多肽泡腾片的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020039597A1 (en) * 1998-04-20 2002-04-04 Koji Ukai Stabilized compositions containing benzimidazole-type compounds
CN1266652A (zh) * 1999-03-12 2000-09-20 江苏康禾食品总厂 氨基酸泡腾剂
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
CA2560595C (en) * 2004-03-29 2013-01-22 Wyeth Multi-vitamin and mineral nutritional supplements
CN1327838C (zh) * 2004-07-08 2007-07-25 北京科信必成医药科技发展有限公司 维生素c口腔崩解片及其制备方法
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
CA2750216A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
US20130052278A1 (en) * 2010-03-11 2013-02-28 Rich Vitamins Llc Quick dissolve nutritional powder
CN102406623B (zh) * 2010-09-26 2014-08-27 上海星泰医药科技有限公司 一种尼索地平控释片剂及其制备方法
WO2012085043A2 (en) * 2010-12-22 2012-06-28 Basf Se Rapidly disintegrating, solid coated dosage form
WO2013159861A1 (de) * 2012-04-27 2013-10-31 Merck Patent Gmbh Tabletten mit überzug und deren herstellung
CN104382934A (zh) * 2013-08-19 2015-03-04 宣城柏维力生物工程有限公司 一种孕妇多维片
CN103751327B (zh) * 2014-01-15 2016-08-24 刘保国 葡萄糖酸锌vc泡腾片
CN104432060B (zh) * 2014-12-18 2016-10-05 郑州拓洋实业有限公司 一种高锌低钠维生素c泡腾片及其制备方法
CN104784206B (zh) * 2015-03-16 2017-07-14 浙江圣博康药业有限公司 一种多维元素分散片
WO2017123103A1 (en) 2016-01-15 2017-07-20 Dee, Kennie U. Stable and palatable composition of vitamin c and zinc lozenge tablets

Also Published As

Publication number Publication date
KR20180064420A (ko) 2018-06-14
PH12018500791B1 (en) 2018-10-29
PH12018500791A1 (en) 2018-10-29
KR102089721B1 (ko) 2020-03-16
HK1257130A1 (zh) 2019-10-11
TW201716063A (zh) 2017-05-16
WO2017065623A1 (en) 2017-04-20
CN108347990A (zh) 2018-07-31
MY191729A (en) 2022-07-13

Similar Documents

Publication Publication Date Title
DOP2016000049A (es) Modulación de la inmunidad tumoral
PH12016501236A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
TR201906843T4 (tr) Hızlı etkili insülin bileşimleri.
BR112016021680A2 (pt) carbonato de cálcio reagido na superfície, e, composição de cuidado oral
CY1119151T1 (el) Ν-(4-(αζαϊνδαζολ-6-υλ)-φαινυλ)-σουλφοναμιδiα και η χρηση τους ως φαρμακα
CL2015001461A1 (es) Una formulación estabilizada de pemetrexed.
DK3024814T3 (da) Fedtsyrediamider baseret på cycloalifatiske og alifatiske diaminer anvendt som organogelatorer
TWD166031S (zh) 口含物
MX361837B (es) Combinación de sujetador de cabeza rebajada y destornillador.
PH12016500874A1 (en) Two part oxidizing system for oral care compositions
BR112018007634A2 (pt) tablete oral revestido estável
EP3219318A4 (en) Multi-layered tablet containing drug unstable with respect to light
EA201890828A1 (ru) Оптимизированная таблетка с высокой дозой активного соединения, содержащая месалазин
HUE064808T2 (hu) Prekurzor vegyületek az A5-vitamin útvonal retinoidjainak elõállítására és azok alkalmazása
EP3094384A4 (en) Oxygen supply with carbon dioxide scrubber for emergency use
WO2015101670A3 (en) Inhibitors of 17beta-hydroxysteroid dehydrogenases type 1 and type 2
IN2014DN07191A (pt)
BR112018013689A2 (pt) composição estável e palatável de comprimidos de pastilha em forma de losango de vitamina c e zinco
CY1121388T1 (el) Παραγωγα βενζυλυδροξειδιου, παρασκευη αυτων και θεραπευτικη χρηση αυτων
IL251770B (en) Granules of an active substance with a double taste masking technique, a method for their production and orally disintegrating tablets containing them
EA201891885A1 (ru) Содержащая прегабалин высоконабухаемая трехслойная таблетка с замедленным высвобождением для перорального приема
UA103360U (en) Means acting on mixed-nematosis cestodosis invasion of chicken
UA100326U (ru) Применение натриевой соли гидрогенсульфида для потенцирования анальгетического эффекта нестероидных противовоспалительных препаратов
UA77230U (ru) «ампролев» Комплексный препарат для лечения гетеракозно-гистомонозной инвазии птицы
UA100327U (ru) Применение натриевой соли гидрогенсульфида для потенцирования антифлогогенной активности нестероидных противовоспалительных препаратов

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: KENNIE DEE (PH) ; RITA JOSEFINA SANTOS (PH) ; WEND

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 870180055359 DE 27/06/2018, E NECESSARIO APRESENTAR DOCUMENTO DEVIDAMENTE NOTARIZADO E COM APOSTILAMENTO OU LEGALIZACAO CONSULAR, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25B Requested transfer of rights rejected

Owner name: KENNIE DEE (PH) ; RITA JOSEFINA SANTOS (PH) ; WEND

Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870180055359 DE 27/06/2018, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2513, DE 06/03/2019.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements